All lobbying clients
BIOGEN, INC.
Lobbying client · District of Columbia · filed 2025 to 2026
Biotechnology Company.
$8,820,000
Reported spend
32
Filings counted
4
Outside firms hired
12
Bills named
Who filed for this client
5
- BIOGEN $7,560,000
- DLA PIPER LLP (US) $360,000
- FEDERAL STREET STRATEGIES, LLC $350,000
- TODD STRATEGY GROUP $350,000
- JEFFREY J. KIMBELL & ASSOCIATES, INC. $200,000
Bills named in these filings
12
Reported by year
2 years
- 2026 $3,880,000
- 2025 $4,940,000
Issues lobbied
8
Agencies and chambers lobbied
9
- HOUSE OF REPRESENTATIVES
- SENATE
- Centers For Medicare and Medicaid Services (CMS)
- Health & Human Services, Dept of (HHS)
- White House Office
- Treasury, Dept of
- U.S. Trade Representative (USTR)
- Executive Office of the President (EOP)
- Veterans Affairs, Dept of (VA)
Recent filings
33 total
Q3 report
View →
Q3 report
View →
Q3 report
View →
Q3 report
View →
Q2 report
View →
Q2 report
View →
Q2 report
View →
Q2 report
View →
Q1 report
View →
Q1 report
View →
Q1 report
View →
Q4 termination amendment
View →
Q1 report
View →
Q4 report
View →
Q4 report
View →
Q4 report
View →
Q4 report
View →
Q4 termination
View →
Q3 report
View →
Q3 report
View →
FEDERAL STREET STRATEGIES, LLC
DLA PIPER LLP (US)
BIOGEN
TODD STRATEGY GROUP
FEDERAL STREET STRATEGIES, LLC
TODD STRATEGY GROUP
BIOGEN
DLA PIPER LLP (US)
FEDERAL STREET STRATEGIES, LLC
BIOGEN
TODD STRATEGY GROUP
JEFFREY J. KIMBELL & ASSOCIATES, INC.
DLA PIPER LLP (US)
FEDERAL STREET STRATEGIES, LLC
TODD STRATEGY GROUP
DLA PIPER LLP (US)
BIOGEN
JEFFREY J. KIMBELL & ASSOCIATES, INC.
Amended
FEDERAL STREET STRATEGIES, LLC
TODD STRATEGY GROUP